Marshall Fordyce - Aug 19, 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
President and CEO, Director
Signature
/s/ Joseph R. Young
Stock symbol
VERA
Transactions as of
Aug 19, 2022
Transactions value $
$0
Form type
4
Date filed
8/23/2022, 04:03 PM
Previous filing
Aug 15, 2022
Next filing
Sep 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Award $0 +43.8K +31.84% $0.00 181K Aug 19, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under Issuer's 2021 Equity Incentive Plan. One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney